Literature DB >> 7935706

Therapeutic-class wars--drug promotion in a competitive marketplace.

D A Kessler1, J L Rose, R J Temple, R Schapiro, J P Griffin.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7935706     DOI: 10.1056/NEJM199411173312007

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  24 in total

1.  Did the major clinical trials of statins affect prescribing behaviour?

Authors:  M M Mamdani; J V Tu
Journal:  CMAJ       Date:  2001-06-12       Impact factor: 8.262

Review 2.  Why training is the key to successful guideline implementation.

Authors:  A D Paltiel; P J Neumann
Journal:  Pharmacoeconomics       Date:  1997-09       Impact factor: 4.981

3.  'Me-Too' Innovation in Pharmaceutical Markets.

Authors:  Anupam B Jena; John E Calfee; Edward C Mansley; Tomas J Philipson
Journal:  Forum Health Econ Policy       Date:  2009-11-04

4.  Drug discovery: lessons from evolution.

Authors:  John Warren
Journal:  Br J Clin Pharmacol       Date:  2011-04       Impact factor: 4.335

5.  Timing and Characteristics of Cumulative Evidence Available on Novel Therapeutic Agents Receiving Food and Drug Administration Accelerated Approval.

Authors:  Huseyin Naci; Olivier J Wouters; Radhika Gupta; John P A Ioannidis
Journal:  Milbank Q       Date:  2017-06       Impact factor: 4.911

6.  The impact of incremental innovation in biopharmaceuticals: drug utilisation in original and supplemental indications.

Authors:  Ernst R Berndt; Iain M Cockburn; Karen A Grépin
Journal:  Pharmacoeconomics       Date:  2006-12       Impact factor: 4.981

7.  Physician prescribing behavior and its impact on patient-level outcomes.

Authors:  Geoffrey F Joyce; Mariana P Carrera; Dana P Goldman; Neeraj Sood
Journal:  Am J Manag Care       Date:  2011-12-01       Impact factor: 2.229

8.  What kind of patients and physicians value direct-to-consumer advertising of prescription drugs.

Authors:  F F Gönül; F Carter; J Wind
Journal:  Health Care Manag Sci       Date:  2000-06

9.  Study of neurontin: titrate to effect, profile of safety (STEPS) trial: a narrative account of a gabapentin seeding trial.

Authors:  Samuel D Krumholz; David S Egilman; Joseph S Ross
Journal:  Arch Intern Med       Date:  2011-06-27

Review 10.  Clinical trial design and selected drug safety issues for antibiotics used to treat community-acquired pneumonia.

Authors:  Bruce M Psaty
Journal:  Clin Infect Dis       Date:  2008-12-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.